MedTrace Logo

Gastrointestinal Tolerance, Satiation and Sensory Acceptance of Yogurts Containing Dietary Fiber and Coffee Cascara Extract

NCT03539146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-08-22

No results posted yet for this study

Summary

Coffee processing byproducts, such as coffee cascara (outer skin and pulp of the coffee berry), have potential health promoting properties due to the presence of bioactive compounds. Its use as a novel food ingredient is a means of valorizing this fractioin in the elaboration of functional yogurts. The addition of cascara extract in yogurt affects its texture quality. The addition of dietary fiber can help regain the structure of the yogurt's gel. However, secondary gastrointestinal effects associated with acute fiber ingestion must be considered.The aim of this clinical trial is to study the gastrointestinal tolerance, satiation and sensory acceptance of yogurts containing both coffee cascara extract and different doses of commercial soluble dietary fiber.

Conditions

  • Satiation
  • Gastrointestinal Tolerance
  • Organoleptic Appreciation

Interventions

OTHER

Dietary fiber

Intake of yogurt containing cascara with 0%, 3%, 7%,13% dietary fiber in a crossover design.

OTHER

Control yogurt

Control yogurt

Sponsors & Collaborators

  • Madrid Institute of Rural Development, Agronomy and Food Research (IMIDRA)

    collaborator UNKNOWN

  • National Research Council, Spain

    lead OTHER_GOV

Principal Investigators

  • Maria Dolores del Castillo, PhD · Institute of Food Science Research (CIAL-CSIC)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03539146 on ClinicalTrials.gov